Measurement of Glycaemic Responses of Bakery and Confectionery Products
NCT ID: NCT01454219
Last Updated: 2012-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2011-08-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of Glycemic and Insulinemic Indices
NCT01477216
Glucose and Insulin Responses to Test Foods
NCT01671878
Evaluation of Glycemic Index, Glycemic Load and Insulinemic Index of Spanish Breads
NCT02297074
The Glycemic and Insulinemic Responses Elicited by Meals Containing Whole Grain Rye Bread or White Wheat Bread
NCT02400411
Determination of Glycemic Index (GI) of Ten Food Products
NCT01679704
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bakery and confectionary products
Control product: Glucose solution, Test products: 11 bakery and confectionary products
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy man or women, age between 18 ang 65 years
* regular eating
* Body Mass Index 18,5 - 24,9 kg/m2
Exclusion Criteria
* gastrointestinal diseases
* hepatic, kidney, pancreas or thyroid disease or disorder
* arthritis
* pregnancy or breast feeding
* smoking
* allergy
* severe diseases
* blood donation
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fazer
OTHER
Clinical Life Sciences Ltd.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Päivi Cheney, MD
Role: PRINCIPAL_INVESTIGATOR
Tiina Suutari, M.Sc.
Role: STUDY_DIRECTOR
Clinical Life Sciences Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Life Sciences Ltd
Kajaani, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIFA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.